Skip to content

Study · Not a test of the peptide alone · 2001

1 result

Peptidergic correction of the effect of acute hypobaric hypoxia in pregnant rats on progeny.

Maslova MV, Zemlyanskii KS, Shkol'nikova MV, Maklakova AS, Krushinskaya YV, Sokolova NA, Ashmarin IP

Bulletin of experimental biology and medicine1 Feb 2001Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Semax was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Semax.

  1. 01AnimalNot a test of Semax aloneAnimal study (in vivo)Efficacy outcome

    In pregnant rats exposed to acute hypobaric hypoxia, preventive intranasal instillation of a Semax and beta-casomorphin-7 mixture prevented the hypoxia effect on the progeny.

    In plain wordsIn rats, a nasal mixture of Semax and beta-casomorphin-7 given to pregnant females prevented the harm that lack of oxygen caused in their pups.

    Peptide
    Semax
    Outcome
    Not applicableProgeny development after prenatal hypoxia
    Study

    ratn: not reported in source

    Pups of pregnant rats exposed to acute hypobaric hypoxia
    Outcome group
    Pregnancy and fetal development · Whole body

    Source sentences

    Summary
    Preventive intranasal instillations of peptide mixture (semax and beta-casomorphine-7) to pregnant females prevented the effect of hypoxia on the progeny.
    1 context sentence
    Summary · context
    Acute hypobaric hypoxia of pregnant rats led to a significant delay in body weight gain, growth and time of eye opening in newborn rat pups which was paralleled by behavioral changes.

    In this study, Semax was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semax.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 10:21 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.